Paracetamol overdose: toxicity, metabolism and antidote
Paracetamol is widely used for pain and fever, and at recommended doses it is generally safe. An overdose, however, can quietly overwhelm the liver’s defence against its reactive metabolites. Understanding that biochemical pathway explains why treatment cannot wait for symptoms.
Paracetamol is also called acetaminophen in many countries. The distinction matters for Australian patients, clinicians and Nepali chemists working across both settings, where early assessment and appropriate antidote therapy can prevent severe liver failure.
From tablet to reactive metabolite
Most paracetamol is transformed in the liver into inactive metabolites. A smaller fraction undergoes cytochrome P450 oxidation, especially through CYP2E1 and CYP3A4, producing N-acetyl-p-quinone imine, or NAPQI. Glutathione normally neutralises this reactive metabolite. A visual periodic table guide offers a quick chemistry refresher.
In overdose, NAPQI production can outstrip the body’s glutathione supply. Once glutathione stores are depleted, NAPQI can bind cellular proteins and disrupt mitochondrial function, triggering oxidative stress and hepatocyte death. Liver cells may begin failing before pain or other warning signs become obvious.
Delayed injury and risk factors
Signs of liver injury often emerge 24–72 hours after ingestion, although serious effects can develop earlier. Initial symptoms may be limited to nausea, vomiting and loss of appetite. Later findings include right-upper-abdominal pain, jaundice, confusion, abnormal clotting and kidney injury; a well-looking person is not necessarily safe.
Risk rises with chronic alcohol use, fasting or malnutrition, low body weight, pre-existing liver disease and repeated supratherapeutic doses. Alcohol induces some CYP enzymes and can reduce glutathione reserves, while an empty stomach can alter metabolism. These factors can matter even when the stated dose does not look extreme.
Clinical assessment combines the ingestion history, paracetamol concentration, liver tests, coagulation studies and markers of organ injury. For a single acute ingestion, a blood paracetamol concentration measured four hours after ingestion can support risk assessment. Unknown timing, repeated dosing or extended-release products require different sampling strategies and toxicology advice.
N-acetylcysteine in clinical practice
N-acetylcysteine, or NAC, is the antidote of choice. It supplies cysteine for glutathione synthesis and can bind NAPQI directly. Its benefit is greatest when given early, ideally within eight hours, but treatment after that window may still help and should be judged by timing, symptoms and laboratory results.
Australian emergency departments use oral or intravenous NAC according to the circumstances and local protocols. Vomiting, fluid considerations and previous reactions influence the choice, while monitoring includes liver function, clotting, electrolytes and kidney function. Rare bronchospasm and gastrointestinal effects can occur, so treatment is supervised rather than self-administered.
For children, body weight and formulation are central to every decision. Significant exposure, uncertainty about the amount taken, or concerning symptoms require urgent assessment, even when the early clinical picture appears reassuring.
Australian safeguards, services and study
Australia’s Therapeutic Goods Administration restricts sales of larger paracetamol packs to pharmacies and limits their promotional display. This reflects the local market’s approach to a useful medicine with a narrow margin between therapeutic and toxic exposure. Pharmacists can also identify repeated or excessive purchases that may need review.
In hospital talk in Australia, the emergency department is commonly called the ‘ED’, and ‘paracetamol’ is the standard spoken name, although imported packets may say acetaminophen. Major public EDs in Melbourne, Sydney and Perth assess poisoning, while ambulance charges vary by state and territory, so practical access advice belongs beside the clinical guidance.
Clinical training in Australia includes pharmacy, toxicology and emergency medicine placements. For Nepali students planning overseas study, a letter of acceptance guide can help with the application stage, although each Australian university sets its own academic, English-language and visa conditions.
Bedside comparisons and immediate response
Different exposure patterns create different clinical problems. A single acute overdose is assessed mainly against time and drug concentration; repeated supratherapeutic use may cause injury without a single high dose; and a late presentation may already include established hepatic damage. None should be managed by waiting for symptoms.
| Exposure pattern | Main concern | Typical clinical approach |
|---|---|---|
| Recommended therapeutic dosing | Usual NAPQI production is adequately neutralised | No antidote is normally required unless an additional overdose or concerning findings occur |
| Single acute overdose | NAPQI accumulation and potentially severe hepatic necrosis | Urgent assessment, timed concentration and NAC according to local risk criteria |
| Repeated supratherapeutic use | Cumulative liver injury with few early warning signs | Early toxicology review and treatment guided by history, liver tests and coagulation results |
| Late presentation | Established liver injury or substantial uncertainty about risk | Immediate assessment, NAC consideration and close monitoring of liver and kidney function |
The next step in a suspected paracetamol overdose is immediate medical assessment through 000 or the Poisons Information Centre on 13 11 26, with the medicine packet brought for the treating team.